These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 8783816

  • 1. Dose-response relationship of cytochrome P4501b1 mRNA induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in livers of C57BL/6J and DBA/2J mice.
    Abel J, Li W, Döhr O, Vogel C, Donat S.
    Arch Toxicol; 1996; 70(8):510-3. PubMed ID: 8783816
    [Abstract] [Full Text] [Related]

  • 2. Biphasic response for hepatic microsomal enzyme induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice.
    Shen ES, Guengerich FP, Olson JR.
    Biochem Pharmacol; 1989 Nov 15; 38(22):4075-84. PubMed ID: 2512931
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Walker NJ, Portier CJ, Lax SF, Crofts FG, Li Y, Lucier GW, Sutter TR.
    Toxicol Appl Pharmacol; 1999 Feb 01; 154(3):279-86. PubMed ID: 9931287
    [Abstract] [Full Text] [Related]

  • 4. Physiological modeling of a proposed mechanism of enzyme induction by TCDD.
    Kohn MC, Walker NJ, Kim AH, Portier CJ.
    Toxicology; 2001 May 21; 162(3):193-208. PubMed ID: 11369115
    [Abstract] [Full Text] [Related]

  • 5. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities.
    Vogel C, Donat S, Döhr O, Kremer J, Esser C, Roller M, Abel J.
    Arch Toxicol; 1997 May 21; 71(6):372-82. PubMed ID: 9195019
    [Abstract] [Full Text] [Related]

  • 6. Induction and localization of cytochrome P450 1B1 (CYP1B1) protein in the livers of TCDD-treated rats: detection using polyclonal antibodies raised to histidine-tagged fusion proteins produced and purified from bacteria.
    Walker NJ, Crofts FG, Li Y, Lax SF, Hayes CL, Strickland PT, Lucier GW, Sutter TR.
    Carcinogenesis; 1998 Mar 21; 19(3):395-402. PubMed ID: 9525272
    [Abstract] [Full Text] [Related]

  • 7. Synergistic interactions of 2,3,7,8-TCDD and 2,2',4,4',5,5'-hexachlorobiphenyl in C57BL/6J and DBA/2J mice: role of the Ah receptor.
    Bannister R, Safe S.
    Toxicology; 1987 May 21; 44(2):159-69. PubMed ID: 3031851
    [Abstract] [Full Text] [Related]

  • 8. Ah receptor regulation of CYP1B1 expression in primary mouse embryo-derived cells.
    Alexander DL, Eltom SE, Jefcoate CR.
    Cancer Res; 1997 Oct 15; 57(20):4498-506. PubMed ID: 9377560
    [Abstract] [Full Text] [Related]

  • 9. 7,12-Dimethylbenz[a]anthracene inhibition of steroid production in MA-10 mouse Leydig tumor cells is not directly linked to induction of CYP1B1.
    Mandal PK, McDaniel LR, Prough RA, Clark BJ.
    Toxicol Appl Pharmacol; 2001 Sep 15; 175(3):200-8. PubMed ID: 11559018
    [Abstract] [Full Text] [Related]

  • 10. Differential time-course and dose-response relationships of TCDD-induced CYP1B1, CYP1A1, and CYP1A2 proteins in rats.
    Santostefano MJ, Ross DG, Savas U, Jefcoate CR, Birnbaum LS.
    Biochem Biophys Res Commun; 1997 Apr 07; 233(1):20-4. PubMed ID: 9144388
    [Abstract] [Full Text] [Related]

  • 11. Ah receptor in mice genetically "nonresponsive" for cytochrome P4501A1 induction: cytosolic Ah receptor, transformation to the nuclear binding state, and induction of aryl hydrocarbon hydroxylase by halogenated and nonhalogenated aromatic hydrocarbons in embryonic tissues and cells.
    Harper PA, Golas CL, Okey AB.
    Mol Pharmacol; 1991 Nov 07; 40(5):818-26. PubMed ID: 1658612
    [Abstract] [Full Text] [Related]

  • 12. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism.
    Larsen MC, Angus WG, Brake PB, Eltom SE, Sukow KA, Jefcoate CR.
    Cancer Res; 1998 Jun 01; 58(11):2366-74. PubMed ID: 9622076
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
    Angus WG, Larsen MC, Jefcoate CR.
    Carcinogenesis; 1999 Jun 01; 20(6):947-55. PubMed ID: 10357772
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modulation of cytochrome P450 1 (Cyp1) by vanadium in hepatic tissue and isolated hepatocyte of C57BL/6 mice.
    Abdelhamid G, Amara IE, Anwar-Mohamed A, El-Kadi AO.
    Arch Toxicol; 2013 Aug 01; 87(8):1531-43. PubMed ID: 23423713
    [Abstract] [Full Text] [Related]

  • 18. Modulation of prostaglandin H synthase-2 mRNA expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice.
    Vogel C, Schuhmacher US, Degen GH, Bolt HM, Pineau T, Abel J.
    Arch Biochem Biophys; 1998 Mar 15; 351(2):265-71. PubMed ID: 9514655
    [Abstract] [Full Text] [Related]

  • 19. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility.
    van Duursen MB, Sanderson JT, van den Berg M.
    Toxicol Sci; 2005 May 15; 85(1):703-12. PubMed ID: 15659568
    [Abstract] [Full Text] [Related]

  • 20. Rat CYP1B1: an adrenal cytochrome P450 that exhibits sex-dependent expression in livers and kidneys of TCDD-treated animals.
    Walker NJ, Gastel JA, Costa LT, Clark GC, Lucier GW, Sutter TR.
    Carcinogenesis; 1995 Jun 15; 16(6):1319-27. PubMed ID: 7788849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.